首页> 外国专利> LECTIN PATHWAY DEFICIENCY ASSAY

LECTIN PATHWAY DEFICIENCY ASSAY

机译:莱克丁通道缺陷检测

摘要

The invention refers to an in vitro method of functionally determining at physiological conditions deficiencies in the lectin pathway of the complement system, the method comprising the steps of (a) providing a sample of mammalian blood, serum, plasma or anotehr body fluid; (b) preventing in the sample the activation of the calssical pathway by contacting the sample with an inhibitor of a molecule of the C1 complex of the complement system; (e) preventing in the sample the activation of the alternative pathway; (d) activating the lectin pathway in the sample; and (e) determining in the sample any activation of the autologous C5b-9 complex. The invention also refers to a kit for functionally determining in a body fluid from a mammal deficiencies in the lectin pathway of the complement system, which kit comprises the separate items (a) an inert carrier and a substance activating the lectin pathway; (b) a diluent comprising an inhibitor of a molecule of the C1 complex; and an antibody against the autologous C5b-9 complex.
机译:本发明涉及一种在生理条件下功能性测定补体系统的凝集素途径中的缺陷的体外方法,该方法包括以下步骤:(a)提供哺乳动物血液,血清,血浆或anotehr体液的样品; (b)通过使样品与补体系统的C1复合物的分子的抑制剂接触来防止样品中钙通道的激活; (e)防止样本中替代途径的激活; (d)激活样品中的凝集素途径; (e)确定样品中自体C5b-9复合物的任何活化。本发明还涉及一种用于在功能上确定来自补体系统的凝集素途径的缺陷的哺乳动物的体液的试剂盒,该试剂盒包括单独的物品:(a)惰性载体和激活凝集素途径的物质; (b)稀释剂,其包含C1复合物分子的抑制剂;和针对自体C5b-9复合物的抗体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号